More on QNCX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-3,880.0% Growth)
- Ratings (6.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Quince Therapeutics (NQ:QNCX)
Delayed: 28.96 --0 (-0%)
Prev. Close $28.96  
Open$28.96 
52 Wk High$ 
52 Wk Low$ 
Day High$28.96 
Day Low$28.96 
P/E N/A  
EPS$ 
Volume2 


Aug 27, 2026 04:31 PM Form 8-K Quince Therapeutics, For: Aug 23
Aug 25, 2026 08:31 AM Form DEF 14A Quince Therapeutics, For: Oct 06
Aug 25, 2026 06:04 AM Form EFFECT Quince Therapeutics,
Aug 20, 2026 07:16 AM Craig-Hallum Starts Quince Therapeutics Inc. (QNCX) at Buy
Aug 18, 2026 09:00 AM Cantor Fitzgerald Reiterates Overweight Rating on Quince Therapeutics Inc. (QNCX)
Aug 17, 2026 06:14 AM Form 8-K Quince Therapeutics, For: Aug 17
Aug 14, 2026 09:21 PM Form SCHEDULE 13G Quince Therapeutics, Filed by: Ikarian Capital, LLC
Aug 14, 2026 04:49 PM Form SCHEDULE 13G/A Quince Therapeutics, Filed by: Nantahala Capital Management, LLC
Aug 14, 2026 04:11 PM Form 10-Q Quince Therapeutics, For: Jun 30
Aug 14, 2026 02:05 PM Form SCHEDULE 13G Quince Therapeutics, Filed by: Cormorant Asset Management, LP
View All Articles

Entities mentioned with QNCX

View All Entities